Atlas Trials

A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.

Clinical trial NCT03254199 · TERMINATED

Trial details

NCT number
NCT03254199
Sponsor
Flex Pharma, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Charcot-Marie-Tooth Disease
Start date
2017-10-16
Primary completion
2018-07-27
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.